CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Harmony Biosciences Holdings, Inc.

HRMY
$2.41BMid Cap

Next catalyst

PDUFAApr 1, 2027in 135 days

Pitolisant GR

Narcolepsy (gastro-resistant formulation)

Get an email about HRMY's next catalysts

Track Harmony Biosciences Holdings (HRMY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (PDUFA date).See the timeline

Catalyst Timeline

3 upcoming, 1 past

PDUFA

FDA PDUFA Date HBS-102 (standard)

Jan 18, 2027HBS-102

For narcolepsy. NDA filing. Extracted from SEC filing: 8-K

Source
Earnings
✓Positive

HRMY Earnings Report

Apr 1, 2027

EPS Est: $1.00 | FQ end Sep/2026 | Call: bmo

Q3 2026 WAKIX net revenue of $269M with 400 net patient adds; positive preliminary MAD data for BP-205 showing favorable safety, tolerability and PK after 14 days of once-daily dosing; no liver or visual adverse events or clinically significant cardiovascular events; Pitolisant GR NDA under FDA review.

PDUFANext

FDA PDUFA Date Pitolisant GR

Apr 1, 2027Pitolisant GR

For Narcolepsy (gastro-resistant formulation). NDA accepted in July 2026. Verified against the company SEC filing on 2026-10-16.

Source

Upcoming FDA decisions

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical Preparations🇺🇸North AmericaPLYMOUTH MEETING268 employees
Drug Pipeline

No drugs found in this phase.

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

When is Harmony Biosciences Holdings, Inc.'s next FDA catalyst?→

Harmony Biosciences Holdings, Inc.'s (HRMY) next tracked catalyst is a PDUFA date expected Apr 1, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track HRMY biotech catalysts?→

Add HRMY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Harmony Biosciences Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply